{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:26:51Z","timestamp":1793226411265,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.canlet.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T22:15:22Z","timestamp":1620771322000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cytomegalovirus infection of glioblastoma cells leads to NF-\u03baB dependent upregulation of the c-MET oncogenic tyrosine kinase"],"prefix":"10.1016","volume":"513","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9001-8006","authenticated-orcid":false,"given":"Harald","family":"Krenzlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykola","family":"Zdioruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal O.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Finkelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naureen","family":"Keric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-6497","authenticated-orcid":false,"given":"Niels","family":"Lemmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-5415","authenticated-orcid":false,"given":"Magdalena","family":"Skubal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Antonio","family":"Chiocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-3616","authenticated-orcid":false,"given":"Charles H.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-2339","authenticated-orcid":false,"given":"Sean E.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.05.005_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11060-015-1734-0","article-title":"Cytomegalovirus and glioblastoma; controversies and opportunities","volume":"123","author":"Lawler","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.05.005_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2021.05.005_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.05.005_bib4","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","article-title":"Adult glioblastoma","volume":"35","author":"Alexander","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.05.005_bib5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.05.005_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.05.005_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2021.05.005_bib8","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.celrep.2017.05.040","article-title":"MicroRNA-Mediated dynamic bidirectional shift between the subclasses of glioblastoma stem-like cells","volume":"19","author":"Rooj","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2021.05.005_bib9","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/0008-5472.CAN-15-3432","article-title":"Extracellular vesicles from high-grade glioma exchange diverse pro-oncogenic signals that maintain intratumoral heterogeneity","volume":"76","author":"Ricklefs","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","article-title":"Chellenges to curing primary brain tumors","volume":"16","author":"Aldape","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.05.005_bib11","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1038\/s41388-020-1193-8","article-title":"MET targeting: time for a rematch","volume":"39","author":"Koch","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2021.05.005_bib12","series-title":"Regulation of HGF Expression by Delta EGFR-Mediated C-Met Activation in Glioblastoma Cells","first-page":"73","author":"Garnett","year":"2013"},{"key":"10.1016\/j.canlet.2021.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9070087","article-title":"Role and therapeutic targeting of the HGF\/MET pathway in glioblastoma","volume":"9","author":"Cruickshanks","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.05.005_bib14","doi-asserted-by":"crossref","first-page":"21141","DOI":"10.1038\/srep21141","article-title":"Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.05.005_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11060-015-1723-3","article-title":"High levels of c-Met is associated with poor prognosis in glioblastoma","volume":"122","author":"Petterson","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.05.005_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2021.05.005_bib17","first-page":"3347","article-title":"Human cytomegalovirus infection and expression in human malignant glioma","volume":"62","author":"Cobbs","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1215\/15228517-2007-035","article-title":"Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma","volume":"10","author":"Mitchell","year":"2008","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.05.005_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00401-008-0359-1","article-title":"Detection of human cytomegalovirus in different histological types of gliomas","volume":"116","author":"Scheurer","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2021.05.005_bib20","article-title":"Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients","volume":"1","author":"Foster","year":"2019","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.canlet.2021.05.005_bib21","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1128\/JVI.00015-12","article-title":"Genetic analysis of cytomegalovirus in malignant gliomas","volume":"86","author":"Bhattacharjee","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.05.005_bib22","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1158\/1078-0432.CCR-16-1490","article-title":"Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry, and in situ hybridization","volume":"23","author":"Holdhoff","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","article-title":"The landscape of viral associations in human cancers","volume":"52","author":"Zapatka","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2021.05.005_bib24","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/MCB.23.6.1885-1895.2003","article-title":"Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors","volume":"23","author":"Kalejta","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2021.05.005_bib25","doi-asserted-by":"crossref","first-page":"ra58","DOI":"10.1126\/scisignal.2001180","article-title":"HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis","volume":"3","author":"Slinger","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2021.05.005_bib26","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1158\/0008-5472.CAN-14-3307","article-title":"Cytomegalovirus immediate-early proteins promote stemness properties in glioblastoma","volume":"75","author":"Soroceanu","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMc1302145","article-title":"Survival in patients with glioblastoma receiving valganciclovir","volume":"369","author":"Soderberg-Naucler","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.05.005_bib28","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1158\/1078-0432.CCR-20-0369","article-title":"Valganciclovir as add-on to standard therapy in glioblastoma patients","volume":"26","author":"Stragliotto","year":"2020","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ijc.28111","article-title":"Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study","volume":"133","author":"Stragliotto","year":"2013","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2021.05.005_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature14320","article-title":"Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients","volume":"519","author":"Mitchell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.05.005_bib31","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1158\/1078-0432.CCR-20-1082","article-title":"Once, twice, three times a finding: reproducibility of dendritic cell vaccine trials targeting cytomegalovirus in glioblastoma","volume":"26","author":"Batich","year":"2020","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMc0804818","article-title":"Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate","volume":"359","author":"Prins","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.05.005_bib33","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1078-0432.CCR-16-2057","article-title":"Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination","volume":"23","author":"Batich","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/0008-5472.CAN-17-0469","article-title":"Dendritic cells enhance polyfunctionality of adoptively transferred T cells that target cytomegalovirus in glioblastoma","volume":"78","author":"Reap","year":"2018","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib35","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/neuonc\/now120","article-title":"Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain","volume":"18","author":"Goerig","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.05.005_bib36","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-19-3195","article-title":"Early mortality of brain cancer patients and its connection to cytomegalovirus reactivation during radiochemotherapy","volume":"26","author":"Goerig","year":"2020","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib37","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/1078-0432.CCR-20-0646","article-title":"Cytomegalovirus encephalopathy during brain tumor irradiation","volume":"26","author":"Lawler","year":"2020","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1172\/JCI123375","article-title":"Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis","volume":"129","author":"Krenzlin","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2021.05.005_bib39","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-12-3846","article-title":"Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations","volume":"73","author":"Price","year":"2013","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/cancers11040447","article-title":"Latent cytomegalovirus infection in female mice increases breast cancer metastasis","volume":"1","author":"Yang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.05.005_bib41","first-page":"7345","article-title":"A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo","volume":"63","author":"Christensen","year":"2003","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2021.05.005_bib42","doi-asserted-by":"crossref","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2021.05.005_bib43","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1128\/jvi.69.9.5391-5400.1995","article-title":"Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105\/p50 and p65 promoters","volume":"69","author":"Yurochko","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.05.005_bib44","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/JVI.78.9.4498-4507.2004","article-title":"Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter","volume":"78","author":"DeMeritt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.05.005_bib45","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/j.1460-2075.1989.tb08610.x","article-title":"NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation","volume":"8","author":"Sambucetti","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2021.05.005_bib46","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/jcb.22226","article-title":"The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival","volume":"107","author":"Dai","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.05.005_bib47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.molcel.2020.05.015","article-title":"Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed form the PD-L1 locus","volume":"78","author":"Mineo","year":"2020","journal-title":"Mol. Cell."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:56:21Z","timestamp":1759593381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":47,"alternative-id":["S0304383521002111"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.05.005","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus infection of glioblastoma cells leads to NF-\u03baB dependent upregulation of the c-MET oncogenic tyrosine kinase","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}